Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jul;35(4-5):542-8.
doi: 10.1007/BF02405091.

Effects of epidermal growth factor on osteoblastic cells in vitro

Effects of epidermal growth factor on osteoblastic cells in vitro

M Kumegawa et al. Calcif Tissue Int. 1983 Jul.

Abstract

The effect of epidermal growth factor (EGF) on clone MC3T3-El cells that have osteoblastic activity was examined by phase-contrast microscopy and electron microscopy; hydroxyproline content, collagen synthesis, collagen pattern, and alkaline phosphatase (ALP) activity were also determined. We found that EGF (0.4 ng/ml) transformed the cells from their normal polygonal shape to a spindle-like morphology by 8 h. This hormone also caused dose-related suppression of hydroxyproline content and ALP activity which was detectable 2 days and 1 day, respectively, after EGF addition. Indomethacin did not affect hydroxyproline content and ALP activity, suggesting that the effect of EGF on the cells may not be mediated by prostaglandins. Epidermal growth factor at concentrations of 2 to 50 ng/ml significantly decreased collagen synthesis in the cells, whereas protein synthesis was stimulated. Electron microscopy demonstrated that collagen fiber formation was also reduced by EGF; an immature type of fibril was observed compared with the typical cross-striated one in the controls. Moreover, the hormone treatment also resulted in the appearance of type III collagen in addition to the type I already present in the cells. These suppressive effects of EGF on MC3T3-El cells in vitro suggest that this hormone may be involved in bone remodelling in vivo as well.

PubMed Disclaimer

References

    1. J Biol Chem. 1962 May;237:1555-62 - PubMed
    1. Biochemistry. 1971 Mar 16;10(6):988-94 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1481-5 - PubMed
    1. Science. 1977 Aug 19;197(4305):776-8 - PubMed
    1. J Biol Chem. 1972 Dec 10;247(23):7609-11 - PubMed